
RNase, back in the early 1990s, posed a serious threat to laboratories working withย RNA isolation. My graduate work involved isolating RNA from the tissues of Lyme disease-infected mice and hamsters. We struggled to DEPC-treat glass and plasticware, or autoclave anything that could be autoclaved, kept tissues cold during RNA harvest and held our breaths (truly, as aerosol could be another source of ribonuclease) until PAGE proved usย successful in RNA isolation.
Ribonuclease (RNase) was omnipresent and the arch rival of ourย work,ย across several species,ย due to its RNA destroying abilities.
Now, aย July 13, 2015 publication by researchers at the University of Wisconsin-Madison provided both a catch-up for this former lab rat on modern day research with and knowledge of RNase, as well asย an exciting look at what mayย be a real purpose for this RNA-destroying molecule: RNase has moved to clinical trials due to the discovery of itโs cytotoxicity for cancer cells.
Rainesโ group in the Department of Chemistry at UWI-Madison published in ACS Central Scienceย their findings on the ligand that RNaseย 1 uses to attach to human cancer cells, in theย article, โHuman Cancer Antigen Globo H is a Cell-Surface Ligand for Human Ribonuclease 1โ. Continue reading “A Reason for Ribonuclease: From Laboratory Nuisance to Cancer Therapeutic”

